Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Benjamin Machinas Beneski

Svp, Chief Technical Officer at Allogene Therapeutics, Inc. (ALLO)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $52K

Reported trades

Filed Stock Type Shares Price Value Since
Apr 2SEC ALLOAllogene Therapeutics, Inc. Sell 2,867195,338 held (−1%) $2.50 $7K -41.6%
Mar 18SEC ALLOAllogene Therapeutics, Inc. Sell 4,835198,205 held (−2%) $2.47 $12K -40.9%
Mar 4SEC ALLOAllogene Therapeutics, Inc. Sell 7,132203,040 held (−3%) $2.60 $19K -43.8%
Feb 4SEC ALLOAllogene Therapeutics, Inc. Sell 7,549210,172 held (−3%) $1.73 $13K -15.6%
Nov 19SEC ALLOAllogene Therapeutics, Inc. Sell 786217,721 held (−0%) $1.22 $959 +19.7%